Skip to main content
. 2017 Sep 23;9:10–13. doi: 10.1016/j.ajoc.2017.09.004

Fig. 3.

Fig. 3

Molecularpathological analyses of the skin lesion. Next-generation sequencing using Ion AmpliSeqTM Cancer Hotspot Panel v2 revealing FGFR3 (p.F386L) missense mutation.